• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 5. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143

Professional Introduction to Ethyl 1-aminocycloheptane-1-carboxylate (CAS No. 85911-50-8)

Ethyl 1-aminocycloheptane-1-carboxylate, a compound with the chemical formula C₁₀H₁₉NO₂ and CAS number 85911-50-8, is a significant molecule in the field of pharmaceutical chemistry and drug development. This compound belongs to the class of cycloalkyl amines and has garnered attention due to its potential applications in medicinal chemistry and biotechnology.

The structure of ethyl 1-aminocycloheptane-1-carboxylate features a cycloheptane ring substituted with an amino group at the first carbon and a carboxylate ester at the same position. This unique structural framework makes it a versatile intermediate in synthesizing more complex molecules. The presence of both an amine and a carboxylate group allows for further functionalization, making it a valuable building block in the synthesis of active pharmaceutical ingredients (APIs).

In recent years, ethyl 1-aminocycloheptane-1-carboxylate has been studied for its pharmacological properties. The cycloalkylamine moiety is known to interact with various biological targets, including enzymes and receptors, which are crucial in drug design. Researchers have been exploring its potential as a precursor in the development of novel therapeutic agents targeting neurological disorders, such as Parkinson's disease and Alzheimer's disease.

One of the most intriguing aspects of ethyl 1-aminocycloheptane-1-carboxylate is its role in the synthesis of chiral compounds. The cycloheptane ring provides a rigid scaffold that can be used to create enantiomerically pure compounds, which are essential in many pharmaceutical applications. The ability to produce enantiomerically pure forms of drugs can significantly enhance their efficacy and reduce side effects, making this compound particularly valuable in the pharmaceutical industry.

Recent studies have also highlighted the compound's potential in the development of anti-inflammatory agents. The amine group in ethyl 1-aminocycloheptane-1-carboxylate can be modified to produce derivatives that interact with inflammatory pathways. For instance, researchers have synthesized analogs that mimic the activity of nonsteroidal anti-inflammatory drugs (NSAIDs), demonstrating the compound's potential as a lead structure for new anti-inflammatory medications.

The synthesis of ethyl 1-aminocycloheptane-1-carboxylate involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Common synthetic routes include cyclization reactions followed by nucleophilic substitution to introduce the amine and ester groups. Advanced techniques such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions have also been employed to improve the efficiency of the synthesis.

The compound's stability under various conditions is another critical factor in its application. Ethyl 1-aminocycloheptane-1-carboxylate has been found to be stable under standard storage conditions, making it suitable for long-term use in research laboratories and industrial settings. However, its reactivity with strong acids and bases must be considered during handling and storage to prevent degradation.

In conclusion, ethyl 1-aminocycloheptane-1-carboxylate (CAS No. 85911-50-8) is a multifaceted compound with significant potential in pharmaceutical research and drug development. Its unique structural features make it an excellent intermediate for synthesizing complex molecules, particularly those targeting neurological and inflammatory disorders. As research continues to uncover new applications for this compound, its importance in medicinal chemistry is likely to grow even further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)